Kepler Cheuvreux downgraded Valerio Therapeutics shares from Hold to Reduce, significantly lowering the price target to EUR0.01 from EUR0.10. The downgrade follows the company's announcement of a ...

People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced improved quality of life, clinical outcomes and well-being, as well as fewer ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

February is American Heart Month, a highlight of which is Wear Red Day, which aims to raise awareness about heart disease in ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

Doctors groups signed on to lawsuits seeking to overturn policies that limit gender-affirming care for minors and remove some public-facing health information.

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Students from the Health Sciences Charter School explored careers in medicine and research during a recent visit to ...